###begin article-title 0
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 177 237 177 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Betaretrovirus, Gammaretrovirus, Deltaretrovirus, Spumavirus</italic>
###xml 242 252 242 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 850 858 850 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1283 1293 1283 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 415 420 <span type="species:ncbi:4932">yeast</span>
###xml 503 532 <span type="species:ncbi:11657">bovine immunodeficiency virus</span>
###xml 534 537 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 546 557 <span type="species:ncbi:11741">visna virus</span>
###xml 559 562 <span type="species:ncbi:11741">MVV</span>
###xml 568 598 <span type="species:ncbi:11665">equine infectious anemia virus</span>
###xml 600 604 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 913 917 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 981 986 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1040 1043 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1110 1113 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1118 1122 <span type="species:ncbi:11665?1.0">EIAV</span>
Transcriptional co-activator LEDGF/p75 is the major cellular interactor of HIV-1 integrase (IN), critical to efficient viral replication. In this work, a series of INs from the Betaretrovirus, Gammaretrovirus, Deltaretrovirus, Spumavirus and Lentivirus retroviral genera were tested for interaction with the host factor. None of the non-lentiviral INs possessed detectable affinity for LEDGF in either pull-down or yeast two-hybrid assays. In contrast, all lentiviral INs examined, including those from bovine immunodeficiency virus (BIV), maedi-visna virus (MVV) and equine infectious anemia virus (EIAV) readily interacted with LEDGF. Mutation of Asp-366 to Asn in LEDGF ablated the interaction, suggesting a common mechanism of the host factor recognition by the INs. LEDGF potently stimulated strand transfer activity of divergent lentiviral INs in vitro. Unprecedentedly, in the presence of the host factor, EIAV IN almost exclusively catalyzed concerted integration, whereas HIV-1 IN promoted predominantly half-site integration, and BIV IN was equally active in both types of strand transfer. Concerted BIV and EIAV integration resulted in 5 bp duplications of the target DNA sequences. These results confirm that the interaction with LEDGF is conserved within and limited to Lentivirus and strongly argue that the host factor is intimately involved in the catalysis of lentiviral DNA integration.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 168 180 168 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Retroviridae</italic>
###xml 269 283 269 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Betaretrovirus</italic>
###xml 285 300 285 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gammaretrovirus</italic>
###xml 302 317 302 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Deltaretrovirus</italic>
###xml 319 329 319 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spumavirus</italic>
###xml 334 344 334 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 372 387 372 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alpharetrovirus</italic>
###xml 392 409 392 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Epsilonretrovirus</italic>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 521 526 <span type="species:ncbi:9606">human</span>
###xml 540 545 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 550 555 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1063 1068 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Retroviruses are distinguished by reverse transcription of their RNA genomes and integration of the resulting cDNA replicas into a host cell chromosome. Members of the Retroviridae family can be subdivided into several genera, of which five were isolated from mammals: Betaretrovirus, Gammaretrovirus, Deltaretrovirus, Spumavirus and Lentivirus. The two remaining genera, Alpharetrovirus and Epsilonretrovirus, are retroviruses from birds and fish respectively [(1) and ]. DNA integration is essential for replication of human lentiviruses HIV-1 and HIV-2 and is fundamental to the viral persistence that leads to AIDS (2-4) (). Integrase (IN) is the virus-encoded enzyme responsible for the key catalytic events associated with integration [reviewed in (5)]. IN acts on the linear double stranded cDNA molecule generated by reverse transcription of the retroviral genomic RNA. In a reaction termed 3'-processing, IN trims the 3'-termini of the cDNA exposing 3' hydroxyls of the invariant CA dinucleotides. A dinucleotide is removed from the U3 and U5 termini of HIV-1 cDNA. Next, IN inserts the processed 3'-termini of the viral cDNA into opposing strands of the chromosomal DNA. Integrated viral cDNA is initially flanked by a pair of short single-stranded gaps, which are repaired by host cell enzymes to produce a stable provirus.
###end p 4
###begin p 5
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 728 729 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 190 211 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 213 216 <span type="species:ncbi:11786">MLV</span>
###xml 444 449 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 451 456 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 458 487 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 489 492 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 495 525 <span type="species:ncbi:11665">equine infectious anemia virus</span>
###xml 527 531 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 537 566 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
###xml 568 571 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 674 677 <span type="species:ncbi:11786">MLV</span>
###xml 803 814 <span type="species:ncbi:11963">foamy virus</span>
###xml 816 819 <span type="species:ncbi:11963">PFV</span>
Retroviral integration is not entirely random with respect to the target DNA. Weak consensus integration site sequences have been reported for HIV-1, avian sarcoma leukosis virus (ASLV) and murine leukemia virus (MLV) (6). Furthermore, on the genomic scale retroviruses display distinct, genus-specific patterns of preferred integration regions [reviewed in (7)]. The lentiviruses whose integration site preferences have been reported to-date [HIV-1, HIV-2, simian immunodeficiency virus (SIV), equine infectious anemia virus (EIAV) and feline immunodeficiency virus (FIV)] share a strong bias toward integration within transcription units (8-13), whereas a gammaretrovirus MLV favors transcription start sites and CpG islands (9). Integration of an alpharetrovirus ASLV and a spumaretrovirus prototype foamy virus (PFV) appears to correlate only weakly with gene expression (14-17). These observations collectively suggested a play of virus- or genus-specific mechanisms for integration target selection.
###end p 5
###begin p 6
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 1086 1088 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1172 1174 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 1335 1337 1331 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 1461 1463 1457 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1464 1466 1460 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 1467 1469 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1470 1472 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 177 182 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 717 722 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 955 960 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1229 1234 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1404 1409 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Of several cellular proteins implicated in retroviral integration, transcriptional co-activator p75 received considerable attention since its identification as an interactor of HIV-1 IN (18-20) [for recent reviews see (21,22)]. P75, commonly referred to as lens epithelium-derived growth factor (LEDGF), is a nuclear chromatin-associated protein, ubiquitously expressed at all stages of development (23-26). Early work has implicated LEDGF and its alternative splice form p52 in regulation of gene expression (23,27,28). Recently, LEDGF was shown to associate with JPO2, an interactor of the transcription factor and proto-oncogene c-Myc, corroborating its role in transcription regulation (29). LEDGF interacts with HIV-1 IN via the integrase binding domain (IBD) found within its C-terminal region (residues 347-429) (24,30). A solution structure of the isolated IBD and a crystal structure of the IBD in complex with the catalytic core domain (CCD) of HIV-1 IN have been recently reported (31,32). The IBD adopts a compact, alpha-helical fold, reminiscent of a pair of HEAT repeats (31). The tip of its finger-like structure binds at the dimer interface of the IN CCD (32). In addition to the CCD, the aminoterminal domain of HIV-1 IN required for high-affinity binding is thought to be involved in the protein-protein interaction (25). LEDGF dramatically alters biochemical properties of recombinant HIV-1 IN and potently stimulates its enzymatic activity (18,24,33,34).
###end p 6
###begin p 7
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 846 854 846 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 324 329 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 415 420 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 497 502 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 737 742 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 799 804 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 876 888 <span type="species:ncbi:10710">phage lambda</span>
###xml 1092 1097 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
When expressed in human cells, HIV-1 IN stably associates with mitotic chromosomes (35,36). This property was found to be strictly dependent on the endogenous LEDGF, which appears to tether the viral protein to chromosomal DNA (20,25,37,38). These findings suggested that through its interaction with IN, LEDGF could direct HIV-1 preintegration complex (PIC) to its preferred genomic loci. Concordantly, functional HIV-1 PICs could be immunoprecipitated with antibodies to LEDGF (37). Activity of HIV-1 PICs partially disrupted by treatment in high ionic strength conditions could be rescued by recombinant LEDGF (39). Moreover, a partial knock-down of endogenous LEDGF in target cells resulted in statistically-significant reduction of HIV-1 integration into transcription units (40). In addition, HIV-1 integration could be in part re-targeted in vitro to the vicinity of a phage lambda repressor binding site by a chimeric protein containing the IBD fused to the DNA binding domain of lambda repressor (41). Current reports from several groups indicate that LEDGF plays a critical role in HIV-1 DNA integration and is required for efficient viral replication (42-45) ().
###end p 7
###begin p 8
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 609 619 609 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 68 73 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 78 81 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 108 111 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 201 204 <span type="species:ncbi:11786">MLV</span>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 382 385 <span type="species:ncbi:11786">MLV</span>
###xml 417 422 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 427 430 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 525 530 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In addition to HIV-1 IN, LEDGF was shown to bind primate lentiviral HIV-2 and SIV INs, as well as divergent FIV IN; whereas no interaction was detected between LEDGF and the INs from a gammaretrovirus MLV, deltaretrovirus human T cell lymphotropic virus type 2 (HTLV-2) and alpharetrovirus ASLV (20,34,37). Accordingly, knock-down of LEDGF expression in target cells did not affect MLV, while significantly impairing HIV-1 and FIV integration (45). Although a functional interaction with LEDGF has only been demonstrated for HIV-1 IN, the available data seem to indicate it is universal within but limited to Lentivirus. The present study was designed to test this conjecture and to clarify whether the modulation of enzymatic activities by LEDGF is a conserved feature of lentiviral INs.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Viral DNA and PCR primers
###end title 10
###begin p 11
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 112 123 <span type="species:ncbi:11741">visna virus</span>
###xml 125 128 <span type="species:ncbi:11741">MVV</span>
###xml 131 160 <span type="species:ncbi:11657">bovine immunodeficiency virus</span>
###xml 162 165 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 168 172 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 174 195 <span type="species:ncbi:11768">feline leukemia virus</span>
###xml 197 201 <span type="species:ncbi:11768">FeLV</span>
###xml 207 210 <span type="species:ncbi:11963">PFV</span>
###xml 271 296 <span type="species:ncbi:11855">Mason-Pfizer monkey virus</span>
###xml 298 302 <span type="species:ncbi:11855?1.0">MPMV</span>
###xml 348 352 <span type="species:ncbi:11855?1.0">MPMV</span>
Molecular clones KV1772 (46), pBIV127 (47), pSPeiav19 (48), pEECC-FeLV (49), pcHSRV2 (50) were sources of maedi-visna virus (MVV), bovine immunodeficiency virus (BIV), EIAV, feline leukemia virus (FeLV) and PFV DNA, respectively. Genomic DNA of Akata cells infected with Mason-Pfizer monkey virus (MPMV) served as template for amplification of the MPMV IN coding sequence (CDS). HTLV-1 DNA was from a clinical isolate.
###end p 11
###begin p 12
The following oligodeoxynucleotides were synthesized by Invitrogen: PC122, GCGCGTCGACTTCTTTTTGTATTTCTTTTGGTGG; PC123, TGTGGATAGAAAATATTCCC; PC124, GCGCGTCGACATTTGGTTTTATTAGTAACTTAGTCC; PC125, TGTGGGTAGAAAATATTCAGG; PC126, GCGCGTCGACCGAACTCCCATCTTGGATATC; PC127, TGTTCCTAGAAAATATCCCCTC; PC138, CCCCACAGTACTGTTGGGTGTTCTTCACC; PC139, GGCGGGTACCTTCAGCTCGTGTAGCTCA; PC140, CACCCAACAGTACTGTGGGGCAGGGTGG; PC141, GGCGGAATTCGTACAGAGTGAAGATATGG; PC142, TCAGGGACCCGGGTTCCTAGAAAATATCCCCT; PC143, GCCTTGAAGTCCTCTTTCAGGGACCCGGGTTCC; PC144, GGCCCTCGAGTCACGAACTCCCATCTTGG; PC145, GCGCGTCGACTTCATTTTTTTCCAAATGATCCATTG; PC146, TGAAAGGATATCCCAAACAATATAC; PC155, TGTTCCTGGAAAAAATAGAGCC; PC156, GCGCGTCGACTGCCATTTCTCCATCCTC; PC160, GCGCGTCGACATTGAACAAGATGGATTGCACG; PC161, TGAGTAACATAAACACAAACCTCG; PC169, GGCGGGTACCGGCACTCAGATTCTGCGGTC; PC170, GGCGGAATTCCAATTGTCAGAATACAAGCAC; PC171, CCCACAGTACTGTAGGATCTCGAACAG; PC172, GATCCTACAGTACTGTGGGGTTTTTATGAGG; PC173, GAGCCCCGGGTGGGTAGAAAATATTCAGG; PC174, GCGCGGATCCTCAATTTGGTTTTATTAGTAACTTAG; PC175, TGCAGCTCTCTCCTGCAGACC; PC176, GCGCGTCGACCCCATGGTGTTGGTGGTCTTTTTCTTTGG; PC186, GCGCGTCGACAGTTCCACGAGAGAGTC; PC187x, TGCCCACTGAACTTATAGAGG; PC188, TACCTGGTACCTGTACTGGGTCTCTCTGG; PC192, GGCGGGTACCAGAAAGCAGGTAGCTTGCAGTGG; PC193, GGCGGGTACCCGAAGAACTCCAGCATGAGATCC; PC200, CGCACCTCCTCCCTGGGCTTCGGAC; PC203, TTTTCCTTATTTTCTGAGTAAGG; PC204, GAAAGGACAACATGAGAAAGAGGC; PC206, CTATCAATTACACATTAACATACACAC; PC210, GGACTGAGGGGCCTGAAATGAGC; PC214, CCATTACAAACTTCTCAAATGTTCTTTATATTCCAGG; PC217, GTAAGCCCACTGCAAGCTACC; PC218, GGATCTCATGCTGGAGTTCTTCG; T3P, GCAATTAACCCTCACTAAAGG.
###end p 12
###begin title 13
DNA constructs for protein expression
###end title 13
###begin p 14
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 622 623 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 90 95 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 97 100 <span type="species:ncbi:11741">MVV</span>
###xml 102 105 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 107 111 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 113 117 <span type="species:ncbi:11855?1.0">MPMV</span>
###xml 119 123 <span type="species:ncbi:11768">FeLV</span>
###xml 136 139 <span type="species:ncbi:11963">PFV</span>
###xml 592 597 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To make constructs for production of C-terminally His6-tagged INs, DNA fragments encoding HIV-2, MVV, BIV, EIAV, MPMV, FeLV, HTLV-1 and PFV INs were PCR-amplified using Pfu DNA polymerase (Stratagene) and the primer pairs PC155/PC156, PC123/PC122, PC127/PC126, PC125/PC124, PC161/PC160, PC187x/PC186, PC175/PC176 and PC146/PC145, respectively. Resulting amplicons digested with SalI were ligated between NdeI and SalI sites of pET20-b(+) (Novagen) (NdeI site of the vector was filled-in using Pfu polymerase to allow blunt-end ligation). The plasmid pKB-IN6H used for bacterial expression of HIV-1 IN with a C-terminal His6-tag has been described (25).
###end p 14
###begin p 15
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 452 453 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 728 729 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 15 18 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 41 44 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 79 95 <span type="species:ncbi:169066">human rhinovirus</span>
###xml 398 402 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 424 428 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 571 574 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 594 597 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 697 702 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 775 780 <span type="species:ncbi:9606">human</span>
To make pCPH6P-BIV-IN, for production of BIV IN with N-terminal His6-tag and a human rhinovirus (HRV) 3C protease cleavage site, a PCR fragment obtained using primers PC143 and PC144 and re-amplified using primers PC142 and PC144, was digested with XhoI and ligated between NdeI and XhoI sites of pET15b (Novagen) (NdeI site of the vector was filled-in to allow blunt-end ligation). To make pCPH6P-EIAV-IN for expression of EIAV IN with a removable His6-tag, a PCR amplicon obtained with primers PC173 and PC174 was digested with XmaI and BamHI and subcloned into pCPH6P-BIV-IN, to replace the BIV IN CDS. The plasmids pRP1012, pCP-Nat75 and pCP-Nat75(D366N) were used for bacterial expression of HIV-1 IN with an N-terminal His6-tag and a thrombin cleavage site, non-tagged human LEDGF and LEDGF(D366N), respectively (25,31,51).
###end p 15
###begin title 16
DNA substrates for integration assays
###end title 16
###begin p 17
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 47 50 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 320 323 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
###xml 386 390 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 587 590 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
###xml 618 623 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 625 628 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 633 637 <span type="species:ncbi:11665?1.0">EIAV</span>
To make pBIV-U3U5, RU5 and U3 fragments of the BIV long terminal repeat (LTR) were PCR-amplified using primers pairs PC138/PC139 and PC140/PC141 respectively and spliced by re-amplification with primers PC139 and PC141. The resulting amplicon digested with KpnI and EcoRI was ligated between KpnI and EcoRI sites of pBK-RSV (Stratagene). To make pEIAV-U3U5, RU5 and U3 fragments of the EIAV LTR PCR-amplified using primer pairs PC169/PC171 and PC170/PC172 were spliced in a PCR with primers PC169 and PC170. The resulting amplicon was digested with KpnI and EcoRI and subcloned into pBK-RSV. Mini-viral substrates for HIV-1, BIV and EIAV INs were prepared by digestion of pU3U5 (51), pBIV-U3U5 and pEIAV-U3U5 with ScaI, respectively.
###end p 17
###begin p 18
###xml 369 373 369 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 689 691 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 36 39 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 44 48 <span type="species:ncbi:11665?1.0">EIAV</span>
To obtain RU5 substrates for HIV-1, BIV and EIAV INs, PCR fragments obtained using Taq DNA polymerase and T3P primer in combination with PC188, PC139, and PC169, respectively, and pU3U5, pBIV-U3U5 and pEIAV-U3U5 as templates, respectively, were digested with ScaI and the RU5-containing fragments were purified by electrophoresis through 2% agarose gels. The longer RU5+300 donors were obtained in a similar fashion, substituting PC188, PC139 or PC169 for PC210 primer that anneals 300 bp upstream of the KpnI site of the mini-viral constructs. Where indicated, the reactive strands of the RU5 substrates were 5' end labeled using T4 polynucleotide kinase (New England Biolabs) and [gamma-32P]ATP (GE Healthcare).
###end p 18
###begin title 19
Recombinant proteins
###end title 19
###begin p 20
###xml 25 41 25 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">endA</italic>
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 312 315 306 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 379 380 370 371 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 25 41 <span type="species:ncbi:562">Escherichia coli</span>
Endonuclease A-deficient Escherichia coli strain PC2 [BL21(DE3), endA::TetR, T1R, pLysS], recovered as a spontaneous T1 phage-resistant mutant of PC1 (51,52), was used for protein production. Shake flask cultures of PC2 transformed with various expression constructs were grown in LB medium at 30degreesC to an A600 of 0.9-1.0 prior to induction with 0.25 mM isopropyl-thio-beta-d-galactopyranoside. Following 4 h induction at 25-28degreesC, bacteria were harvested and stored at -70degreesC.
###end p 20
###begin p 21
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 384 385 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 859 860 859 860 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 932 933 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1067 1068 1057 1058 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 793 798 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 800 803 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 808 812 <span type="species:ncbi:11665?1.0">EIAV</span>
To isolate His6-tagged retroviral IN proteins, thawed bacterial paste was sonicated in buffer B (1 M NaCl, 7.5 mM CHAPS, 50 mM Tris-HCl, pH 7.4) containing 0.5 mM phenylmethlysulfonyl fluoride and 15 mM imidazole. Crude extracts pre-cleared by centrifugation were incubated with Ni NTA agarose (Qiagen). The resin was extensively washed in buffer B containing 15 mM imidazole, and His6-tagged proteins were eluted with 200 mM imidazole in buffer B. IN-containing fractions diluted with 3 volumes of 50 mM Tris-HCl, pH 7.4 were injected into a 5 ml HiTrap Heparin column (GE Healthcare), and bound proteins were eluted with a linear gradient of 0.25-1 M NaCl in 50 mM Tris-HCl, pH 7.4. Immediately after elution, 10 mM DTT was added to each fraction and NaCl concentration was adjusted to 1 M. HIV-1, BIV and EIAV INs produced to carry cleavable N-terminal His6-tags were digested with thrombin (3 NIH units of thrombin per mg of His6-tagged IN) for 3 h at 25degreesC in the presence of 20 mM beta-mercaptoethanol or HRV14 3C protease (20 mug of protease per mg of His6-tagged IN) for 6-12 h at 4degreesC in the presence of 20 mM DTT; the tag-free INs were then purified by chromatography on Heparin sepharose as above.
###end p 21
###begin p 22
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
Wild type and D366N LEDGF were made as previously described (24,25,31). Purified proteins supplemented with 10% glycerol were flash-frozen in liquid nitrogen and stored at -70degreesC. Protein concentration was determined using Bradford assay (Bio-Rad Laboratories) with a BSA standard. Where indicated, molar concentrations refer to monomer protein forms.
###end p 22
###begin title 23
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
His6-tag pull-down assays
###end title 23
###begin p 24
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 152 153 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 290 291 285 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
His6-tag pull-down assays were done as previously described (25,31). Briefly, 4 mug wild type or D366N LEDGF was incubated with 6.7 mug C-terminally His6-tagged retroviral IN, 10 mug BSA and 15 mul Ni-NTA agarose (settled bead volume) in 650 mul pull-down buffer [PB, 150 mM NaCl, 2 mM MgCl2, 25 mM imidazole, 0.1% Nonidet P40 and 50 mM Tris-HCl (pH 7.4)] for 4-5 h at 4degreesC with gentle rocking. The beads washed trice in ice-cold PB were boiled in 16 mul 2x Laemmli sample buffer containing 50 mM ethylenediaminetetraacetic acid (EDTA) and 50 mM DTT. Eluted proteins were separated by electrophoresis by SDS-PAGE and detected by staining with Coomassie-R250.
###end p 24
###begin title 25
###xml 21 27 <span type="species:ncbi:9796">equine</span>
###xml 32 38 <span type="species:ncbi:9913">bovine</span>
Sequence analysis of equine and bovine LEDGF cDNAs
###end title 25
###begin p 26
###xml 369 383 357 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Equus caballus</italic>
###xml 110 116 <span type="species:ncbi:9796">equine</span>
###xml 369 383 <span type="species:ncbi:9796">Equus caballus</span>
###xml 651 657 <span type="species:ncbi:9796">equine</span>
###xml 780 786 <span type="species:ncbi:9796">equine</span>
###xml 926 932 <span type="species:ncbi:9913">bovine</span>
Two partial cDNA sequences (GenBank accession nos. CX598499 and CD528249) spanning approximately900 bp of the equine LEDGF CDS were identified using translated BLAST. PC204, PC200 and PC206 primers were designed based on this known sequence and conserved portions of 5'- and 3'-untranslated regions (3'-UTRs) of mammalian LEDGF cDNA sequences. Total RNA extracted from Equus caballus-derived cell line NBL-6 was reverse-transcribed using random-primed Superscript III (Invitrogen). Sequencing of a 1 kb PCR fragment obtained using Easy-A DNA polymerase (Stratagene) primed by PC204 and PC206 revealed approximately300 bp of the 3'-UTR sequence of the equine cDNA. Finally, a 1.6 kb PCR fragment obtained using Easy-A with PC200 and PC214 revealed complete and unbiased CDS of the equine LEDGF cDNA. The sequences determined in this work were submitted to GenBank (accession codes DQ829781 and DQ873682). The entire CDS of the bovine LEDGF cDNA could be reconstructed from the available partial sequences (GenBank accession codes AF474175, CR382879, DN537967, DN536615, DT857195, DN533664, DT885845, DV915861, DT896093, DN535088, DV916069, DV913569 and DV827864).
###end p 26
###begin title 27
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro integration assays
###end title 27
###begin p 28
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 392 393 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 407 408 403 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 694 698 676 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 803 807 785 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 32 35 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 39 43 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 152 157 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 591 594 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 597 600 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 607 611 <span type="species:ncbi:11665?1.0">EIAV</span>
Tag-free preparations of HIV-1, BIV or EIAV INs were used in all enzymatic assays. Reaction conditions were essentially as previously described for the HIV-1 enzyme (18,24,31). Briefly, 2 mul IN [in dilution buffer (DB), 750 mM NaCl, 10 mM DTT and 10 mM Tris-HCl (pH 7.8)] or 2 mul DB was added to 36 mul master mixture containing appropriate substrate and target DNA in 42 mM NaCl, 6 mM MgSO4, 4.8 muM ZnCl2, 12.1 mM DTT, and 24.2 mM HEPES, pH 7.4. Samples were incubated at 25degreesC for 5-7 min before addition of 2 mul LEDGF (0-0.54 mg/ml in DB) and then at 37degreesC for 90 min. Mini-HIV, -BIV, and -EIAV donor DNA substrates were used at 2.5 nM (300 ng per 40 mul reaction), RU5 and RU5+300 were used at 10 nM. Supercoiled pGEM-9Zf(-) (300 ng) served as target DNA in the assays with RU5 and RU5+300 donors.
###end p 28
###begin p 29
###xml 587 589 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
Integration reactions were stopped by addition of 0.5% SDS and 25 mM EDTA and deproteinized by digestion with 30 mug proteinase K (Roche Applied Science) for 45-60 min at 37degreesC followed by ethanol precipitation. DNA products separated in 0.8 or 1.5% agarose gels in Tris-acetate-EDTA buffer were visualized by staining with ethidium bromide. Singly-nicked pGEM-9Zf(-) DNA, used as migration standard for agarose gel electrophoresis, was prepared by digestion of the supercoiled plasmid with DNase I (Roche Applied Science) in the presence of saturating amounts of ethidium bromide (53). Radioactively-labeled reaction products were detected and quantified by phosphor autoradiography using a Storm-860 scanner (GE Healthcare).
###end p 29
###begin title 30
###xml 21 24 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 29 33 <span type="species:ncbi:11665?1.0">EIAV</span>
Sequence analysis of BIV and EIAV integration products
###end title 30
###begin p 31
###xml 518 519 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 632 634 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 646 652 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 52 55 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 59 63 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 646 652 <span type="species:ncbi:562">E.coli</span>
Strand transfer products from upscaled reactions of BIV or EIAV INs with the respective RU5 donors and supercoiled pGEM-9Zf(-) target DNA were separated by electrophoresis in 1.5% agarose gels. The linear concerted integration products isolated from the gels were treated with phi29 DNA polymerase (New England Biolabs) in the presence of 200 muM of each deoxynucleotide triphosphate, digested with KpnI, and ligated with KpnI-digested kanamycin-resistance cassette. The cassette, containing the Tn5 aminoglycoside-3'-O-phosphotransferase gene, was obtained in a PCR using Easy-A DNA polymerase, PC192 and PC193 primers, and pCP15 (52) template. E.coli XL1-Blue cells transformed with the ligation products were selected with 35 mug/ml kanamycin. Plasmids isolated from individual colonies were sequenced using primers PC217 and PC218 annealing to the flanking regions of the kanamycin-resistance cassette.
###end p 31
###begin title 32
RESULTS
###end title 32
###begin title 33
Interaction with LEDGF is limited to and conserved among lentiviral INs
###end title 33
###begin p 34
###xml 103 104 103 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 321 330 321 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 393 402 393 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 515 524 515 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 683 692 683 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 801 810 801 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1097 1112 1097 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A and B</xref>
###xml 1201 1210 1201 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 1221 1230 1221 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 280 285 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 290 295 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 453 458 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 577 581 <span type="species:ncbi:11855?1.0">MPMV</span>
###xml 599 603 <span type="species:ncbi:11768">FeLV</span>
###xml 648 651 <span type="species:ncbi:11963">PFV</span>
###xml 730 734 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 736 739 <span type="species:ncbi:11741">MVV</span>
###xml 744 747 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 884 889 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1061 1066 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1087 1092 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A series of IN proteins of lentiviral and non-lentiviral origins produced with identical C-terminal His6-tags were tested for interaction with recombinant human LEDGF in a pull-down assay using Ni-NTA agarose beads (25,31). In agreement with published observations (20,25,31,34), HIV-1 and HIV-2 INs readily bound LEDGF (Figure 1A, lanes 2 and 4). LEDGF was not recovered when IN was omitted (Figure 1B, lane 2), and the Q168A substitution close to the HIV-1 IN binding interface (20,32) precluded the interaction (Figure 1A, lane 3). Under identical conditions betaretroviral MPMV, gammaretroviral FeLV, deltaretroviral HTLV-1 and spumaretroviral PFV INs failed to pull-down LEDGF (Figure 1A, lanes 5-8). In contrast, lentiviral EIAV, MVV and BIV INs reproducibly retained LEDGF on the Ni-NTA beads (Figure 1B, lanes 5-7). LEDGF residue Asp366 plays a crucial role in recognition of HIV-1 IN, forming a bidentate hydrogen bond with main chain amides of IN residues Glu-170 and His-171 (32), and LEDGF mutants D366A and D366N are deficient for interaction with HIV-1 IN (31). Similar to HIV-1 IN (Figure 1A and B, lanes 10), none of the lentiviral INs studied here pulled down the LEDGF D366N mutant (Figure 1A, lane 11; Figure 1B, lanes 12-14), suggesting that divergent lentiviral INs share the structural basis for the host factor recognition.
###end p 34
###begin p 35
###xml 117 125 117 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 331 332 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 457 464 457 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">326&#8211;471</sup>
###xml 66 71 <span type="species:ncbi:4932">yeast</span>
###xml 214 219 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 274 279 <span type="species:ncbi:4932">yeast</span>
###xml 489 493 <span type="species:ncbi:11855?1.0">MPMV</span>
###xml 495 499 <span type="species:ncbi:11768">FeLV</span>
###xml 512 515 <span type="species:ncbi:11963">PFV</span>
###xml 551 556 <span type="species:ncbi:4932">yeast</span>
###xml 642 647 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 652 655 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 765 770 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 775 778 <span type="species:ncbi:11673?1.0">FIV</span>
Recent results indicate that applied to the IN-LEDGF interaction, yeast two-hybrid assays can be more sensitive than in vitro pull-down experiments. Residual interactions between LEDGF and several point mutants of HIV-1 IN (e.g. Q168A, V165A and R166A) could be revealed by yeast two-hybrid analyses, while evading detection by His6-tag pull-down (20,31,54). In agreement with the results of the pull-down assays described here, no interaction between LEDGF326-471 and non-lentiviral INs (MPMV, FeLV, HTLV-1 and PFV) could be detected in a GAL4-based yeast two-hybrid assay, under conditions that readily revealed binding of the co-factor to HIV-1 and FIV INs (Supplementary Figure S1). Furthermore, the D366N mutation in LEDGF disrupted the interactions with both HIV-1 and FIV INs (Supplementary Figure S1), corroborating a common structural mechanism of host factor recognition by divergent lentiviral INs.
###end p 35
###begin title 36
###xml 21 27 <span type="species:ncbi:9913">bovine</span>
###xml 32 38 <span type="species:ncbi:9796">equine</span>
Sequence analysis of bovine and equine LEDGF cDNAs
###end title 36
###begin p 37
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 442 452 442 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.caballus</italic>
###xml 556 568 556 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bovis taurus</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 320 323 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 328 332 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 351 357 <span type="species:ncbi:9913">bovine</span>
###xml 362 368 <span type="species:ncbi:9796">equine</span>
###xml 442 452 <span type="species:ncbi:9796">E.caballus</span>
###xml 505 510 <span type="species:ncbi:9796">horse</span>
###xml 727 732 <span type="species:ncbi:9606">human</span>
###xml 734 740 <span type="species:ncbi:9913">bovine</span>
###xml 745 751 <span type="species:ncbi:9796">equine</span>
###xml 801 807 <span type="species:ncbi:9913">bovine</span>
###xml 812 818 <span type="species:ncbi:9796">equine</span>
###xml 915 920 <span type="species:ncbi:9606">human</span>
###xml 1102 1107 <span type="species:ncbi:9606">human</span>
###xml 1109 1114 <span type="species:ncbi:10090">mouse</span>
###xml 1124 1130 <span type="species:ncbi:9796">equine</span>
###xml 1135 1141 <span type="species:ncbi:9913">bovine</span>
An issue in this study was the use of human LEDGF in various assays with INs from non-primate retroviruses. LEDGF is known to be well conserved in mammals (24). For instance, the human and feline orthologs share 96.4% identical and 97.9% similar residues (30). To justify using human LEDGF in enzymatic assays involving BIV and EIAV INs, sequences of bovine and equine LEDGF cDNAs were analyzed. A DNA fragment spanning the entire CDS of the E.caballus LEDGF cDNA could be amplified by RT-PCR from RNA of horse NBL-6 cells, whereas the complete CDS of the Bovis taurus LEDGF cDNA could be reconstructed from available partial sequences. Alignments of the predicted protein sequences revealed only minor differences between the human, bovine and equine LEDGF orthologs (Supplementary Figure S2). Thus, bovine and equine LEDGF orthologs share approximately97% identical and approximately99% similar residues with the human protein. Of importance, all functional and structural elements so far identified in LEDGF (i.e. the PWWP domain, the IBD, the NLS and the core A/T-hook motifs) are identical in the human, mouse, feline, equine and bovine orthologs.
###end p 37
###begin title 38
LEDGF augments enzymatic activity of divergent lentiviral INs
###end title 38
###begin p 39
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 321 329 321 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">55</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59">59</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 954 956 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 957 959 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 1034 1035 1022 1023 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1206 1214 1194 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 1274 1276 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1349 1357 1337 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 1537 1545 1524 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 1678 1686 1665 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 312 317 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 465 470 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 472 475 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 480 484 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 563 566 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 578 581 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1073 1078 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1080 1083 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1088 1092 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1339 1344 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1399 1402 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1614 1617 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1622 1626 <span type="species:ncbi:11665?1.0">EIAV</span>
LEDGF enhances the strand transfer activity of HIV-1 IN as much as 150-fold under certain in vitro conditions (18,24,31,33). Notably, the LEDGF-dependent reactions take place in the absence of organic solvents or molecular crowding agents, otherwise required to observe efficient magnesium-dependent activity of HIV-1 IN in vitro (51,55-59). To establish whether divergent lentiviral INs respond to LEDGF in a similar way, strand transfer activities of recombinant HIV-1, BIV and EIAV INs on their respective mini-viral substrates were studied side-by-side. Mini-HIV (51), mini-BIV and mini-EAIV substrates, approximately4.5 kb linear blunt-ended DNA molecules flanked by U3 and RU5 fragments of the viral LTRs, were designed to mimic the viral cDNA. In the simplest form of the assay, mini-viral DNA serves as donor and target DNA and strand transfer products can be detected by staining with ethidium bromide following electrophoresis in agarose gels (18,51). Under close-to-physiological solution conditions [115 mM NaCl, 5 mM MgCl2, 10 mM DTT and 20 mM Hepes (pH 7.5)] HIV-1, BIV and EIAV INs were almost inactive in the absence of LEDGF, yielding barely detectable levels of strand transfer products (Figure 2, lanes 2, 7, 12). In agreement with previous observations (18), addition of LEDGF unleashed the strand transfer activity of HIV-1 IN (Figure 2, lanes 3-5). More than 50% of input mini-HIV DNA was converted into various products, including those that failed to enter the 0.8% agarose gel, in the presence of 0.4 muM LEDGF (Figure 2, lane 5). Similarly, LEDGF stimulated strand transfer activities of BIV and EIAV INs on their respective mini-viral DNA substrates (Figure 2, lanes 8-10, 13-15). Of note, the range of reaction products was IN-specific, each enzyme generating a reproducible and unique pattern.
###end p 39
###begin title 40
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Fidelity of LEDGF-dependent strand transfer in vitro varies among INs
###end title 40
###begin p 41
###xml 79 86 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 739 748 739 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">56</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60">60</xref>
###xml 1317 1326 1317 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 1468 1477 1468 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 817 822 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 824 827 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 832 836 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1365 1370 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Although INs mediate concerted integration of both ends of the retroviral cDNA in vivo, their pure recombinant forms are prone to uncoupled single-LTR (termed half-site) strand transfer. IN assays utilizing long mini-viral DNA substrates proved useful to visualize gross strand transfer activity (18,51). However, the complexity of the reaction products hampers their finer analyses. The use of shorter donor substrates in the presence of excess supercoiled target DNA greatly reduce complexity of the reaction products, the major being circular half-site, resulting from integration of a single-LTR into one strand of the target plasmid, and/or linear concerted, from integration of pairs of LTRs into opposing strands of the target DNA (Figure 3A) (56,60). To compare fidelity of LEDGF-dependent strand transfer by HIV-1, BIV and EIAV INs (herein, fidelity refers to relative efficiency of concerted versus half-site strand transfer), the enzymes were incubated with blunt-ended donor DNA molecules containing respective viral RU5 sequences in the presence of supercoiled plasmid DNA (pGEM), and the reaction products were separated in 1.5% agarose gels. Although the reaction products were clearly IN-specific, LEDGF stimulated strand transfer activities of all three enzymes, in a concentration-dependent manner (Figure 3B). In the presence of the host factor, HIV-1 IN produced a distinct ladder of products that migrated above the nicked form of the target DNA (Figure 3B, compare lanes 1, 6 and 17), as expected for products of single and multiple half-site integration events.
###end p 41
###begin p 42
###xml 150 159 138 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 382 391 370 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 456 460 444 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 462 471 450 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 633 642 609 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 705 709 681 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 831 835 807 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 874 883 850 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 1258 1267 1234 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 1414 1418 1378 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 1736 1745 1700 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 1760 1769 1724 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 21 25 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 44 48 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 324 328 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 399 403 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 710 714 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1575 1580 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1594 1598 <span type="species:ncbi:11665?1.0">EIAV</span>
Reactions containing EIAV IN and the 120 bp EIAV RU5 substrate revealed a major product band migrating as a approximately3200 bp linear DNA fragment (Figure 3B, lanes 13-16). The difference in electrophoretic mobility between this product and linearized pGEM (lane 18) was consistent with concerted integration of a pair of EIAV RU5 substrate molecules into the 2912 bp target (see Figure 3A). When EIAV IN was incubated with a 300 bp longer substrate (RU5+300, Figure 3C) the resulting product migrated as a approximately3800 bp DNA fragment, consistent with concerted integration of a pair of 420 bp substrate molecules into pGEM (Figure 3C, lane 10). Furthermore, a reaction containing both RU5 and RU5+300 EIAV substrates resulted in a triplet of bands, of which two migrated as products of reactions containing only RU5 or RU5+300 plus one at an intermediate position (Figure 3C, lane 11). Such a mixed pattern is expected only when two substrate molecules are used simultaneously in a strand transfer reaction; half-site integration would result in only two different product bands. Of note, degradation of target DNA was not observed when donor DNA substrates were omitted, ruling out contamination of the protein preparations by a nuclease activity (Figure 3C, compare lanes 7 and 12). In addition, digests of the material from the approximately3800 bp band with KpnI or StuI, which restrict within the RU5+300 sequence, further confirmed that it consists of linear DNA species flanked by pairs of donor substrate molecules (data not shown). In sharp contrast to its HIV-1 counterpart, EIAV IN produced only a minor fraction of circular half-site products, which were barely detectable following staining with ethidium bromide (Figure 3B, lanes 13-16; Figure 3C, lanes 8-11).
###end p 42
###begin p 43
###xml 93 102 93 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 116 125 116 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 206 215 194 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 234 243 222 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 456 460 432 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 472 481 448 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 589 593 553 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 636 645 600 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 743 747 707 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 911 920 875 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 939 948 903 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 1046 1050 1010 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 1066 1075 1030 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 1128 1132 1092 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 1258 1262 1222 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 1264 1273 1228 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 26 29 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 308 311 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 449 452 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 594 597 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 853 856 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1051 1054 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1113 1116 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
Under similar conditions, BIV IN was proficient in both concerted and half-site integration (Figure 3B, lanes 7-11; Figure 3C, lanes 1-6). The products migrating as a distinct band at approximately3400 bp (Figure 3B, lanes 10 and 11; Figure 3C, lane 3) resulted from concerted integration of pairs of 217 bp BIV RU5 molecules into pGEM. The identity of this band was confirmed by an approximately4000 bp product obtained in a reaction with a 517 bp BIV RU5+300 substrate (Figure 3C, lane 4) and by the characteristic triplet at approximately3400/3700/4000 bp revealed when both RU5 and RU5+300 BIV substrates were used in one reaction (Figure 3C, lane 5). In addition, digests of the 3.7 kb product with KpnI or XhoI, which restrict within RU5+300 DNA, confirmed its identity (data not shown). The circular half-site products obtained in reactions with BIV RU5 substrate migrated above the nicked form of pGEM (Figure 3B, lanes 10 and 11; Figure 3C, lane 3). A slower migrating band of circular half-site products was obtained with the longer RU5+300 BIV substrate (Figure 3C, lane 4). A reaction containing both BIV RU5 and RU5+300 substrates revealed a pair of bands migrating at the positions identical to those from reactions containing either RU5 or RU5+300 (Figure 3C, lane 5), consistent with a single-LTR strand transfer.
###end p 43
###begin p 44
###xml 186 195 186 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">55</xref>
###xml 422 431 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 442 451 442 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 712 721 712 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 1041 1056 1041 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B and C</xref>
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 92 95 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 252 257 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 356 360 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 497 502 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 507 510 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 673 676 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 765 768 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
Further differences between activities of the lentiviral INs were apparent. Thus, HIV-1 and BIV INs effected substantial nicking of pGEM DNA in LEDGF- and donor DNA-independent manners (Figure 3B, compare lanes 3, 8 and 13; Figure 3C, lanes 6 and 12). HIV-1 IN is known to possess a low level of magnesium-dependent endonuclease activity (55). Also, since EIAV IN prepared in a similar way did not relax supercoiled pGEM (Figure 3B, lane 13; Figure 3C, lane 12), endonuclease activity observed in HIV-1 and BIV IN preparations was unlikely due to a contaminant but an intrinsic activity of these enzymes. A high-molecular weight band reproducibly observed in reaction with BIV IN when substrate DNA was omitted (Figure 3C, lane 6 and data not shown) suggested that BIV IN can utilize randomly nicked DNA to initiate strand transfer, though this product was not studied in detail. Multiple integration events (both half-site and concerted) presumably explain additional product bands and smears observed on the ethidium bromide-stained gels (Figure 3B and C).
###end p 44
###begin p 45
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 390 398 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 427 436 401 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 775 783 749 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 905 913 879 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1068 1076 1030 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1223 1231 1185 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 220 225 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 539 544 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 624 629 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 656 660 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 854 857 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1007 1010 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
To selectively detect and quantify strand-transfer products, integration reactions were set-up with radiolabeled RU5 substrates (Figure 4). During the linear phase of the reaction, LEDGF stimulated half-site activity of HIV-1 IN approximately19.6 (+/-0.3) -fold. A light band migrating at approximately3.5 kb, apparently the product of concerted integration, was observed in the reactions (Figure 4, lanes 4-6, also visible in Figure 3B, lane 6). Since this activity could not be detected in the absence of the host factor, stimulation of HIV-1 concerted integration by LEDGF could not be reliably estimated. In contrast to HIV-1 IN, half-site activity of EIAV IN was not changed in the presence of LEDGF, while the concerted integration activity increased at least 60-fold (Figure 4, lanes 19-27). Both half-site and concerted integration activities of BIV IN were equally stimulated by the host factor (Figure 4, lanes 10-18). Although the circular half-site and concerted products of the LEDGF-dependent BIV reaction reached a maximum level at approximately15 min (Figure 4, lane 12), the reaction products forming secondary product bands and smears appeared to accumulate at the expense of the residual free substrate (Figure 4, lanes 13-15).
###end p 45
###begin title 46
###xml 18 21 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 26 30 <span type="species:ncbi:11665?1.0">EIAV</span>
Sequencing of the BIV and EIAV concerted integration products
###end title 46
###begin p 47
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61">61</xref>
###xml 598 608 598 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 943 949 943 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 1615 1624 1615 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 2213 2222 2213 2222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 436 441 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 446 450 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 730 733 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 738 742 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 943 949 <span type="species:ncbi:562">E.coli</span>
###xml 1133 1137 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1161 1164 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1281 1284 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1289 1293 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1395 1399 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1422 1425 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1581 1584 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1642 1646 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1657 1660 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 2250 2254 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 2274 2277 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
The provirus is flanked by a short duplication of chromosomal target DNA sequence (ranging from 4 to 6 bp for different retroviruses), which results from repair of short single-stranded gaps created upon integration of the retroviral cDNA termini into opposing strands (and across the major groove) of chromosomal DNA. Hence, correct duplication of target DNA sequences is a hallmark of legitimate retroviral integration. Specifically, HIV-1 and EIAV proviruses are flanked by 5 bp duplications of target DNA sequences (13,61). The 5 bp duplication can be conceivably expected for other members of Lentivirus. To further characterize the reaction products and verify target site duplications, products of concerted integration of BIV and EIAV RU5 substrates into the pGEM target isolated from agarose gels were treated with strand-displacing phi29 DNA polymerase, prior to ligation with a kanamycin-resistance cassette and transformation into E.coli cells. Plasmids isolated from randomly-picked kanamycin-resistant colonies were sequenced using primers annealing to the flanks of the cassette. Thirty clones derived from the 3.2 kb EIAV and 26 from the 3.4 kb BIV concerted linear integration products were analyzed. In all sequenced integration products, the reactive termini of BIV and EIAV RU5 substrate molecules underwent correct 3'-processing prior to strand transfer. Twenty-six (86.7%) EIAV and seventeen (65.4%) BIV product-derived plasmids had the expected structure, containing pairs of RU5 fragments inserted with 5 bp duplications of the target sequences; two (7.7%) BIV clones had 6 bp duplications (Figure 5A). Curiously, one EIAV- and five BIV- derived clones contained solo RU5 fragments while the second donor fragment was replaced by an A/T base pair, ligated to the cassette. Because these clones had 5 bp duplications of the target sequences, they were most likely derived from legitimate concerted integration. Nicking 5' of the reactive deoxyadenosine within one of the integrated substrate molecules prior to the treatment with phi29 DNA polymerase could explain their occurrence. The remaining clones had deletions or rearrangements, possibly due to the cloning or selection procedures (Figure 5A). In total, 90% (27/30) of EIAV and 92% (24/26) of BIV integration product clones appeared to arise from legitimate concerted integration.
###end p 47
###begin p 48
###xml 155 164 155 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 324 327 324 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bla</italic>
###xml 497 503 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 563 566 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bla</italic>
###xml 944 950 941 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in viv</italic>
###xml 953 954 950 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 955 957 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 1168 1175 1165 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1177 1178 1174 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 1179 1181 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 27 31 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 36 39 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 497 503 <span type="species:ncbi:562">E.coli</span>
###xml 738 742 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 911 916 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 921 925 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 960 963 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1021 1025 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1030 1033 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
Distribution of the cloned EIAV and BIV integration products along the target DNA did not appear entirely random; both hot and cold regions were observed (Figure 5B). Integration events into or close to the replication origin of pGEM were most likely lost due to the cloning procedure. The second avoided region, within the bla gene, was less obvious, as ampicillin was not used to select the integration product libraries. Overexpression of N-terminal fragments of beta-lactamase can be toxic to E.coli cells (unpublished observations). Therefore, disruption of bla on a high-copy plasmid could lead to selective disadvantage. Alignments of local target sequences from cloned concerted integration products revealed a weak consensus for EIAV IN target sequence GTWACNNW (International Union of Biochemistry codes) (Supplementary Figure S3), which is remarkably similar to that elaborated for large datasets of HIV-1 and EIAV integration sites in vivo (6,13). BIV IN displayed less bias towards target DNA sequence. Both EIAV and BIV INs seemed to disfavor integration immediately next to a deoxythimidine; a similar observation can be made for lentiviral integration in vivo (6,13).
###end p 48
###begin title 49
DISCUSSION
###end title 49
###begin p 50
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 134 148 134 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Betaretrovirus</italic>
###xml 153 163 153 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spumavirus</italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 455 469 455 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Betaretrovirus</italic>
###xml 478 493 478 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gammaretrovirus</italic>
###xml 502 517 502 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Deltaretrovirus</italic>
###xml 531 541 531 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spumavirus</italic>
###xml 571 581 571 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 619 627 619 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 631 632 631 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 956 964 956 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 995 997 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 1104 1114 1104 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 224 229 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 471 475 <span type="species:ncbi:11855?1.0">MPMV</span>
###xml 495 499 <span type="species:ncbi:11768">FeLV</span>
###xml 543 546 <span type="species:ncbi:11963">PFV</span>
###xml 651 656 <span type="species:ncbi:4932">yeast</span>
###xml 877 881 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 883 886 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 891 894 <span type="species:ncbi:11741">MVV</span>
###xml 930 935 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 937 942 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 947 950 <span type="species:ncbi:11673?1.0">FIV</span>
Earlier reports suggested that the interaction with LEDGF is a conserved and unique feature of lentiviral INs (18-20,34,37). However, Betaretrovirus and Spumavirus INs were not included in the previous studies. In addition, HIV-1 IN remained a single lentiviral IN whose enzymatic activity was examined in the presence of the co-factor (18,24,33). The present work was designed to complement and extend the prior observations, and included novel INs from Betaretrovirus (MPMV), Gammaretrovirus (FeLV), Deltaretrovirus (HTLV-1) and Spumavirus (PFV) alongside with several Lentivirus INs. The complementary approaches of in vitro His6-tag pull-down and yeast two-hybrid assays failed to detect interaction between LEDGF and any of the non-lentiviral INs from the current study. In contrast, every lentiviral IN tested here displayed affinity for the host factor, including novel EIAV, BIV and MVV INs, as well as previously studied HIV-1, HIV-2 and FIV INs (Figure 1 and Supplementary Figure S1) (18-20,34,37). These results fully confirm that the interaction with LEDGF is limited to and conserved within Lentivirus.
###end p 50
###begin p 51
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 566 581 566 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A and B</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1304 1306 1304 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 1646 1654 1646 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 1787 1795 1787 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 1945 1947 1945 1947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1948 1950 1948 1950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 2066 2068 2066 2068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 2226 2234 2226 2234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 2421 2423 2421 2423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 2473 2481 2473 2481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 2868 2870 2860 2862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 2871 2873 2863 2865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 2936 2944 2928 2936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 3307 3317 3299 3309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 301 306 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 408 413 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 439 444 <span type="species:ncbi:4932">yeast</span>
###xml 975 980 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 990 993 <span type="species:ncbi:11741">MVV</span>
###xml 1094 1099 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1541 1546 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1724 1729 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1815 1820 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2255 2260 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2465 2468 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 2565 2570 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2699 2704 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2858 2863 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In the crystal structure of the HIV-1 IN CCD-IBD complex, the side chain of LEDGF residue Asp-366 is involved in a bidentate hydrogen bond with the main chain amides of Glu-170 and His-171 of IN (32). These contacts are essential, since D366A and D366N mutations in LEDGF ablated the interaction with HIV-1 IN (31). In agreement with previous observations (31,54), D366N LEDGF mutant failed to interact with HIV-1 IN in both pull-down and yeast two-hybrid assays. Moreover, the point mutation also ablated the interaction with all other lentiviral INs studied here (Figure 1A and B, Supplementary Figure S1), strongly arguing that the divergent INs share the mechanism of the host factor recognition. Intriguingly, while LEDGF proteins from the relevant host species are highly conserved [Supplementary Figure S2, see also (24,30)], lentiviral INs display significant sequence variations. Thus, INs from non-primate lentiviruses share only 29-37% identical residues with the HIV-1 protein; MVV IN included in this study appears to be most divergent. As revealed by the crystal structure of the HIV-1 IN CCD-IBD complex, the host factor forms several key contacts with main chain atoms of IN, and the interaction is highly sensitive to the polypeptide backbone conformation at the IN CCD dimer interface (32). Conceivably, structural conservation of lentiviral INs served to maintain the interaction within the genus. Yet, it appears that each lentivirus has evolved a distinct network of additional contacts. Strikingly, the majority of the HIV-1 IN residues that contribute side chains to the interaction are not conserved among lentiviral INs (Figure 6). The most notable differences affect positions corresponding to the HIV-1 residues Ala-128, Ala-129, Trp-131, Trp-132 and Gln-168 (Figure 6). Methyl groups of HIV-1 IN Ala-128 and Ala-129 participate in a hydrophobic pocket that buries the side chain of the LEDGF hotspot residue Ile-365 (31,32). Substitution of Ala-128 or Ala-129 for a bulkier Gln residue significantly affected apparent affinity for LEDGF (54). Nevertheless, lentiviral INs are able to accommodate residues with larger side chains at the equivalent positions, maintaining the interaction with LEDGF (Figure 6). The side chain of HIV-1 IN Trp-131 is involved in hydrophobic contacts with Phe-406 and Val-408 in LEDGF. The bulky hydrophobic Trp residue, critical to the high-affinity interaction (54), is substituted with small polar Asn in FIV IN (Figure 6). The residues 167-171 comprising a connector between alpha4 and alpha5 helices in HIV-1 IN CCD are directly involved in the interaction with LEDGF. The hydrogen bond between the side chains of Gln-168 and Trp-132 in HIV-1 IN is thought to stabilize the conformation of the connector. Although, the interaction is highly sensitive to mutations at the positions 132 and 168 in HIV-1 IN (20,54), neither residue is conserved in non-primate lentiviral INs (Figure 6). A structure of a non-primate lentiviral IN in complex with LEDGF IBD would elucidate the adaptive changes evolved to preserve the interaction. Maintenance of the interaction despite the significant differences between the INs at the sequence level, suggests that engaging LEDGF provided a strong selective advantage and played a vital role in the evolution of Lentivirus.
###end p 51
###begin p 52
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">55</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59">59</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">62</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b63">63</xref>
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 84 87 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 92 96 <span type="species:ncbi:11665?1.0">EIAV</span>
LEDGF robustly stimulated in vitro strand transfer activity of the divergent HIV-1, BIV and EIAV INs. Importantly, in the presence of the co-factor the strand transfer occurred at the physiological salt concentration and did not require molecular crowding agents or dimethyl sulfoxide typically added to observe magnesium-dependent activity of retroviral INs (55-59). Of note, the co-solvent can alleviate dependence of other nucleotidyl transferases from protein co-factors. For instance, Mu phage transposition critically depends on a network of protein-protein and protein-DNA interactions (62). However, all elements of its intricate regulatory circuit, including the host cell factor HU, become dispensable in the presence of dimethyl sulfoxide (63). Stimulation of the divergent lentiviral INs strongly suggests that the host factor is intimately involved in regulation of lentiviral DNA integration.
###end p 52
###begin p 53
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 353 361 353 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 575 583 575 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 793 801 793 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1110 1118 1110 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1190 1198 1190 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1394 1402 1394 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 155 159 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 220 225 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 267 270 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 614 619 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 624 627 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1018 1022 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1385 1390 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Surprisingly, the fidelity of the LEDGF-dependent strand transfer varied broadly: the host factor selectively stimulated concerted integration activity of EIAV IN, triggered almost exclusive half-site strand transfer by HIV-1 IN, and unleashed both activities in the BIV enzyme. Presumably, both viral cDNA termini in vivo and a pair of donor molecules in vitro must be brought together prior to concerted strand transfer. Protein-protein interactions involving IN subunits and possibly co-factors associated with the cDNA ends would mediate such synapsis. The fact that the in vitro LEDGF-dependent activities of HIV-1 and BIV INs fall short of reproducing legitimate integration might indicate a requirement for an additional host cell- or virus- derived co-factor. Conceivably, the minimal in vitro requirements for proper assembly of the lentiviral synaptic complex depend on stability of individual interfaces between the elements of the integration machinery. Thus, a tighter interaction between substrate-bound EIAV IN protomers could make the hypothetic co-factor dispensable for concerted integration in vitro. Further analyses will be necessary to explain the differences between in vitro activities of the lentiviral IVs and the mechanism of stimulation of lentiviral INs by the host factor. Intriguingly, LEDGF can both enhance and ablate concerted integration activity of HIV-1 IN in vitro, depending on the solution conditions and IN/LEDGF input ratio (K. Pandey and D. Grandgenett, personal communication). The available data collectively suggest that LEDGF can be a key regulator of lentiviral integration.
###end p 53
###begin p 54
###xml 358 368 358 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 430 435 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The current generations of retroviral vectors rely on the wild type viral integration machinery that evolved for maximal viral fitness. The safety of gene therapy could be drastically improved if an option of directed integration could be added to these vectors. The strong bias towards integration into transcription units appears to be a unique feature of Lentivirus (8-17), mirroring the genus-specific interaction with LEDGF. HIV-1 integration into transcription units was diminished in cells partially depleted for LEDGF, indicating that the host factor at least contributed to the integration target site selection (40). Alongside with recent work from several laboratories (42-45), the data presented here indicate that LEDGF is hardwired into the mechanism of lentiviral DNA integration. These developments provide a stronger foundation for further research into exploitation of the host factor for directed retroviral gene delivery and as a potential target for antiretroviral therapy.
###end p 54
###begin title 55
SUPPLEMENTARY DATA
###end title 55
###begin p 56
Supplementary Data are available at NAR online.
###end p 56
###begin title 57
Supplementary Material
###end title 57
###begin title 58
[Supplementary Data]
###end title 58
###begin p 59
###xml 229 233 <span type="species:ncbi:11855?1.0">MPMV</span>
###xml 425 429 <span type="species:ncbi:11768">FeLV</span>
I am grateful to Dr. O. Andresson (University of Iceland) for a generous gift of KV1772 DNA (46), Dr C. Bangham (Imperial College London) for HTLV-1 DNA, Drs M. McClure and G. Patton (Imperial College London) for pcHSRV2 DNA and MPMV, Dr G. Towers (University College London) for NBL-6 cells and S. Dustan (Imperial College London) for help with DNA sequence analysis. Molecular clones pBIV127 (47), pSPeiav19 (48) and pEECC-FeLV (49) were obtained through NIH AIDS Research and Reference Reagent Program (Germantown, MD). I thank Drs A. Engelman, N. Vandegraaff, D. Grandgenett, and M. Pizzato for helpful discussions and comments on the manuscript. This study was funded by the Faculty of Medicine of Imperial College London and the Medical Research Council (MRC). Funding to pay the Open Access publication charges for this article was provided by the MRC.
###end p 59
###begin p 60
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement.</italic>
Conflict of interest statement. None declared.
###end p 60
###begin title 61
REFERENCES
###end title 61
###begin article-title 62
The universal virus database ICTVDB
###end article-title 62
###begin article-title 63
###xml 22 57 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells
###end article-title 63
###begin article-title 64
The_Protocol_005_Study_Team
###end article-title 64
###begin article-title 65
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
###end article-title 65
###begin article-title 66
Retroviral DNA integration
###end article-title 66
###begin article-title 67
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 82 103 <span type="species:ncbi:11786">murine leukemia virus</span>
Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites
###end article-title 67
###begin article-title 68
Genome-wide analysis of retroviral DNA integration
###end article-title 68
###begin article-title 69
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 25 30 <span type="species:ncbi:9606">human</span>
HIV-1 integration in the human genome favors active genes and local hotspots
###end article-title 69
###begin article-title 70
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 72 75 <span type="species:ncbi:11786">MLV</span>
Transcription start regions in the human genome are favored targets for MLV integration
###end article-title 70
###begin article-title 71
###xml 29 58 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
Integration site choice of a feline immunodeficiency virus vector
###end article-title 71
###begin article-title 72
###xml 0 29 <span type="species:ncbi:11723">Simian immunodeficiency virus</span>
###xml 75 110 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1
###end article-title 72
###begin article-title 73
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 130 137 130 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 17 52 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
###xml 54 59 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 90 95 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo
###end article-title 73
###begin article-title 74
###xml 27 31 <span type="species:ncbi:11665?1.0">EIAV</span>
The integration profile of EIAV-based vectors
###end article-title 74
###begin article-title 75
###xml 58 86 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 94 101 <span type="species:ncbi:9031">chicken</span>
Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome
###end article-title 75
###begin article-title 76
###xml 24 43 <span type="species:ncbi:11876">avian sarcoma virus</span>
Genome-wide analyses of avian sarcoma virus integration sites
###end article-title 76
###begin article-title 77
###xml 0 11 <span type="species:ncbi:11963">Foamy virus</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Foamy virus vector integration sites in normal human cells
###end article-title 77
###begin article-title 78
###xml 23 34 <span type="species:ncbi:11963">foamy virus</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Genome-wide mapping of foamy virus vector integrations into a human cell line
###end article-title 78
###begin article-title 79
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells
###end article-title 79
###begin article-title 80
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 24 52 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Human cell proteins and human immunodeficiency virus DNA integration
###end article-title 80
###begin article-title 81
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication
###end article-title 81
###begin article-title 82
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cellular co-factors of HIV-1 integration
###end article-title 82
###begin article-title 83
###xml 28 31 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Retroviral DNA integration: HIV and the role of LEDGF/p75
###end article-title 83
###begin article-title 84
Isolation of cDNAs encoding novel transcription co-activators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation
###end article-title 84
###begin article-title 85
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 156 161 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase
###end article-title 85
###begin article-title 86
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells
###end article-title 86
###begin article-title 87
Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (LEDGF/p75) and p52, in the nucleus
###end article-title 87
###begin article-title 88
A novel transcriptional co-activator, p52, functionally interacts with the essential splicing factor ASF/SF2
###end article-title 88
###begin article-title 89
Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress
###end article-title 89
###begin article-title 90
Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin
###end article-title 90
###begin article-title 91
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering
###end article-title 91
###begin article-title 92
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75
###end article-title 92
###begin article-title 93
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
###end article-title 93
###begin article-title 94
###xml 156 163 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo
###end article-title 94
###begin article-title 95
The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding
###end article-title 95
###begin article-title 96
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
High-level expression of active HIV-1 integrase from a synthetic gene in human cells
###end article-title 96
###begin article-title 97
###xml 27 62 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Intracellular transport of human immunodeficiency virus type 1 integrase
###end article-title 97
###begin article-title 98
###xml 72 78 <span type="species:ncbi:10090">murine</span>
LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes
###end article-title 98
###begin article-title 99
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75
###end article-title 99
###begin article-title 100
###xml 216 221 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication
###end article-title 100
###begin article-title 101
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A role for LEDGF/p75 in targeting HIV DNA integration
###end article-title 101
###begin article-title 102
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 40 68 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor
###end article-title 102
###begin article-title 103
###xml 113 141 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Transient and stable knock-down of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus
###end article-title 103
###begin article-title 104
###xml 38 73 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGF/p75 silencing
###end article-title 104
###begin article-title 105
The American Society for Cell Biology 2006 Summer Meeting on
###end article-title 105
###begin article-title 106
###xml 35 38 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
An essential role for LEDGF/p75 in HIV Integration
###end article-title 106
###begin article-title 107
###xml 104 115 <span type="species:ncbi:11741">visna virus</span>
Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus
###end article-title 107
###begin article-title 108
###xml 55 89 <span type="species:ncbi:11657">bovine immunodeficiency-like virus</span>
Molecular cloning of biologically active proviruses of bovine immunodeficiency-like virus
###end article-title 108
###begin article-title 109
###xml 69 85 69 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 69 85 <span type="species:ncbi:562">Escherichia coli</span>
Lentivirus envelope sequences and proviral genomes are stabilized in Escherichia coli when cloned in low-copy-number plasmid vectors
###end article-title 109
###begin article-title 110
###xml 23 44 <span type="species:ncbi:11768">feline leukemia virus</span>
###xml 92 96 <span type="species:ncbi:9685">cats</span>
Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats
###end article-title 110
###begin article-title 111
###xml 0 17 <span type="species:ncbi:11641">Human foamy virus</span>
Human foamy virus reverse transcription that occurs late in the viral replication cycle
###end article-title 111
###begin article-title 112
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Activity of recombinant HIV-1 integrase on mini-HIV DNA
###end article-title 112
###begin article-title 113
###xml 19 35 19 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 19 35 <span type="species:ncbi:562">Escherichia coli</span>
Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant
###end article-title 113
###begin article-title 114
###xml 82 98 82 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 82 98 <span type="species:ncbi:562">Escherichia coli</span>
Homologous pairing in genetic recombination. Purification and characterization of Escherichia coli recA protein
###end article-title 114
###begin article-title 115
###xml 104 112 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 133 138 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structure-based mutagenesis of the integrase-LEDGF/p75 interface uncouples a strict correlation between in vitro protein binding and HIV-1 fitness
###end article-title 115
###begin article-title 116
###xml 30 65 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity
###end article-title 116
###begin article-title 117
###xml 104 112 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells
###end article-title 117
###begin article-title 118
Retroviral DNA integration: reaction pathway and critical intermediates
###end article-title 118
###begin article-title 119
###xml 123 131 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 37 72 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 77 96 <span type="species:ncbi:11876">avian sarcoma virus</span>
HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro
###end article-title 119
###begin article-title 120
###xml 70 105 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 110 121 <span type="species:ncbi:11741">visna virus</span>
Subterminal viral DNA nucleotides as specific recognition signals for human immunodeficiency virus type 1 and visna virus integrases under magnesium-dependent conditions
###end article-title 120
###begin article-title 121
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration
###end article-title 121
###begin article-title 122
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus integration in a cell-free system
###end article-title 122
###begin article-title 123
Transpositional recombination: mechanistic insights from studies of mu and other elements
###end article-title 123
###begin article-title 124
Efficient Mu transposition requires interaction of transposase with a DNA sequence at the Mu operator: implications for regulation
###end article-title 124
###begin article-title 125
ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins
###end article-title 125
###begin title 126
Figures and Tables
###end title 126
###begin p 127
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 522 523 522 523 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 528 529 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 96 101 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 103 106 <span type="species:ncbi:11963">PFV</span>
###xml 108 112 <span type="species:ncbi:11855?1.0">MPMV</span>
###xml 114 118 <span type="species:ncbi:11768">FeLV</span>
###xml 567 572 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 574 578 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 580 583 <span type="species:ncbi:11741">MVV</span>
###xml 588 591 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
Interaction with LEDGF is limited to and conserved among lentiviral INs. (A) His6-tagged HIV-1, HIV-2, PFV, MPMV, FeLV and HTLV-1 INs (as indicated) were tested for the ability to pull-down WT (lanes 2-8) or D366N LEDGF (lanes 10 and 11). Proteins recovered on Ni-NTA agarose beads were separated in SDS-PAGE gels and detected by staining with Coomassie-R250. Lanes 1 and 9 contained input quantities of WT and D366N LEDGF, respectively. The migration positions of LEDGF and molecular weight markers (kDa) are indicated. (B) His6-tag pull-down assays with lentiviral HIV-1, EIAV, MVV and BIV INs (as indicated) and WT (lanes 3-7) or D366N LEDGF (lanes 10-14). Lanes 1 and 8 contained input quantities of WT and D366N LEDGF. IN was omitted from reactions in lanes 2 and 9.
###end p 127
###begin p 128
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 58 61 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 66 70 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 102 105 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 124 127 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 149 153 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 263 268 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 282 285 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 302 306 <span type="species:ncbi:11665?1.0">EIAV</span>
LEDGF stimulates gross strand transfer activity of HIV-1, BIV and EIAV INs. Reactions containing mini-HIV (lanes 1-5), mini-BIV (lanes 6-10) or mini-EIAV (lanes 11-15) DNAs were incubated in the presence of 0.6 muM (approximately20 mug/ml) non-tagged recombinant HIV-1 (lanes 2-5), BIV (lanes 7-10) or EIAV (lanes 12-15) IN. LEDGF was added to the reactions in lanes 3-5, 8-10 and 13-15 at indicated concentrations. The proteins were omitted from the mock reactions in lanes 1, 6 and 11.
###end p 128
###begin p 129
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 572 573 572 573 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1252 1253 1237 1238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1366 1370 1351 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 1586 1590 1571 1575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+300</sup>
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 37 40 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 45 49 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 575 580 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 594 597 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 615 619 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 746 751 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 753 756 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 761 765 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1255 1258 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1275 1279 <span type="species:ncbi:11665?1.0">EIAV</span>
Strand transfer activities of HIV-1, BIV and EIAV INs in the presence of LEDGF. (A) Schematic of in vitro integration with circular DNA target and the expected linear concerted and circular half site strand transfer products. Coordinated insertion of a pair of substrate DNA molecules into opposing strands of target DNA results in a linear concerted integration product (left). Uncoupled insertion of a single substrate molecule into one strand of the target plasmid gives a circular half site product (right). Thick lines are substrate and thin are target-derived DNA. (B) HIV-1 (lanes 1-6), BIV (lanes 7-11), or EIAV (lanes 12-16) RU5 substrates and supercoiled pGEM target DNA were incubated with 0.6 muM (approximately20 mug/ml) recombinant HIV-1, BIV, or EIAV INs and 0-0.4 muM LEDGF, as indicated. Deproteinized reaction products were separated in 1.5% agarose gels and detected by staining with ethidium bromide. Lanes 17 and 18 contained nicked circular and linearized pGEM DNA respectively. Migration positions of DNA markers (kb), pGEM DNA forms [supercoiled multimer (s.c. mult.), nicked circular, linear, and supercoiled (s.c.)], substrate RU5 DNAs, and the reaction products (concerted, half-site, and multiple half-site) are indicated. (C) BIV (lanes 1-6) and EIAV (lanes 7-12) integration reactions were carried out with the respective RU5 or/and RU5+300 substrates. Lanes 13 and 14 contained nicked circular and linearized pGEM DNA, respectively. Migration positions of the two circular half site and three linear concerted integration products derived from RU5 and RU5+300 substrates are indicated.
###end p 129
###begin p 130
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 38 41 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 46 50 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 113 118 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 135 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 154 158 <span type="species:ncbi:11665?1.0">EIAV</span>
Time course of LEDGF-dependent HIV-1, BIV and EIAV integration reactions with radiolabeled donor DNA substrates. HIV-1 (lanes 1-9), BIV (lanes 10-18) and EIAV (lanes 19-27) RU5 substrates were incubated with their respective INs (0.6 muM) for 5-90 min (as indicated), in the presence (lanes 2-6, 11-15 and 20-24) or absence (lanes 7-9, 16-18 and 25-27) of 0.4 muM LEDGF. Deproteinized reaction products separated in 1.5% agarose gels were detected and quantified by phosphor autoradiography. Lanes 1, 10 and 19 contained mock samples where IN and LEDGF were omitted. Migration positions of DNA standards (kb) are indicated. The plot below each gel shows accumulation of the concerted (filled circles) or half-site (triangles) integration products in the presence (discontinuous line) or absence (dashed line) of LEDGF in terms of relative band intensity. Error bars represent SDs calculated from duplicate measurements.
###end p 130
###begin p 131
###xml 64 65 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 298 299 298 299 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 710 713 710 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bla</italic>
###xml 28 32 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 37 40 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 207 211 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 220 223 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 420 424 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 437 440 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
Sequence analysis of cloned EIAV and BIV integration products. (A) Pie charts summarizing the categories of clones obtained by cloning of the gel-purified concerted linear integration products. In total, 30 EIAV- and 26 BIV- derived clones were analyzed. See the Results section for more details. (B) Distribution of the cloned concerted integration events along the pGEM target. The histogram bars represent numbers of EIAV (black) and BIV (gray) integration events within each 25 bp window along the target DNA sequence. The ruler corresponds to nucleotide coordinates within pGEM-9Zf(-) (GenBank accession no. X65312). Positions of the plasmid's replication origin (ori) and the ampicillin resistance gene (bla) are indicated.
###end p 131
###begin p 132
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 191 193 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 552 554 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 650 652 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 180 185 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 425 430 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 590 595 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Partial sequence alignment of lentiviral INs. Secondary structure elements from 2B4J (32) are indicated above the alignment. Residues comprising the alpha4/5 connector (167-171 in HIV-1 IN) (32) are boxed. Residues invariant among all six proteins are white on red background, and those with conserved biochemical properties are bold on yellow background. Blue circles and boxes under the alignment indicate residues that in HIV-1 CCD-IBD structure directly participate in the interaction with LEDGF through side chain or backbone atoms, respectively (32). The numbering corresponds to the HIV-1 sequence. The figure was generated using ESPript-2.2 (64), ().
###end p 132

